[Relationship between tumor necrosis factor genetic polymorphisms and acute lymphocytic leukemia]

Area of Science:

• Genetics
• Immunology
• Oncology

Context:

• Acute lymphocytic leukemia (ALL) is a hematological malignancy sensitive to tumor necrosis factor (TNF).
• Genetic variations within the TNF locus can influence TNF gene expression.
• Investigating specific polymorphisms in TNFα and LTα genes is relevant to understanding ALL pathogenesis.

Purpose:

• To investigate the association between -308 bp polymorphism in the tumor necrosis factor-alpha (TNFα) gene and +252 bp polymorphism in the lymphotoxin-alpha (LTα) gene with the pathogenesis, clinical course, and outcome of ALL.
• To analyze the distribution of TNFα and LTα gene polymorphisms and their haplotypes in Chinese ALL patients and healthy controls.

Summary:

• Polymerase chain reaction (PCR)-restrictive fragment length polymorphism (RFLP) was used to analyze TNFα(-308) and LTα(+252) gene polymorphisms in 29 ALL patients and 72 controls.
• No statistically significant differences in genotype or allele frequencies were observed between ALL patients and controls.
• Furthermore, no significant associations were found between TNF/LT haplotype status and clinical characteristics (sex, WBC count, CNS involvement, therapy response) or survival outcomes in ALL patients.

Impact:

• The findings suggest that the investigated TNFα(-308) and LTα(+252) genetic polymorphisms do not play a crucial role in the pathogenesis, clinical course, or outcome of acute lymphocytic leukemia.
• This research contributes to the understanding of the genetic factors influencing ALL, highlighting that these specific polymorphisms are unlikely targets for prognostic markers or therapeutic strategies in this disease.